SCHEMBL7002903

SCHEMBL7002903

COc1ccc(CCN(CCC(=O)O)S(=O)(=O)c2cccc([N+](=O)[O-])c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 13/20 0.67
MAPK1 P28482 1/20 0.54
F2 P00734 1/20 0.52
HPGD P15428 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002898 1.00 BMP1 (0.67) BMP1MAPK1F2HPGDKMT2A
SCHEMBL7004932 0.93 BMP1 (0.66) BMP1MAPK1F2HPGDKMT2A
SCHEMBL6998726 0.82 BMP1 (0.81) BMP1
SCHEMBL23364658 0.81 TAS2R14 (0.66) MAPK1F2HPGDKMT2A
SCHEMBL29932726 0.81 TAS2R14 (0.66) MAPK1F2HPGDKMT2A
SCHEMBL6999599 0.78 BMP1 (0.61) BMP1
SCHEMBL7008077 0.76 BMP1 (0.77) BMP1
SCHEMBL31337093 0.75 FFAR1 (0.56) HPGDKMT2A
SCHEMBL7008058 0.74 BMP1 (1.00) BMP1
SCHEMBL15267163 0.74 SLC2A1 (0.56) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1154992-A4 N-SUBSTITUTED ARYLSULFONYLAMINO HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF C-PROTEINASE AND FOR TREATING OR PREVENTING DISORDERS RELATED TO UNREGULATED COLLAGEN PRODUCTION FIBROGEN INC (US) 2003-05-28 EP disclosed
EP-1154992-A1 N-SUBSTITUTED ARYLSULFONYLAMINO HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF C-PROTEINASE AND FOR TREATING OR PREVENTING DISORDERS RELATED TO UNREGULATED COLLAGEN PRODUCTION FIBROGEN, INC. (US) 2001-11-21 EP disclosed
WO-2000050390-A1 N-SUBSTITUTED ARYLSULFONYLAMINO HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF C-PROTEINASE AND FOR TREATING OR PREVENTING DISORDERS RELATED TO UNREGULATED COLLAGEN PRODUCTION FIBROGEN, INC. (US) 2000-08-31 WO disclosed